LFG
EXAS

Leverty Financial Group’s Exact Sciences EXAS Stock Holding History

Leverty Financial Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,000
Closed -$219K – 50
2025
Q3 		$219K Hold
4,000
– – 0.06% 39
2025
Q2 		$213K Buy
+4,000
New +$203K 0.06% 41
2025
Q1 		– Sell
-4,000
Closed -$225K – 44
2024
Q4 		$225K Hold
4,000
– – 0.11% 30
2024
Q3 		$272K Buy
+4,000
New +$226K 0.15% 25
2024
Q2 		– Sell
-4,000
Closed -$276K – 35
2024
Q1 		$276K Hold
4,000
– – 0.16% 25
2023
Q4 		$296K Hold
4,000
– – 0.19% 23
2023
Q3 		$273K Hold
4,000
– – 0.2% 19
2023
Q2 		$376K Sell
4,000
-150
-4% -$11.7K 0.27% 16
2023
Q1 		$281K Hold
4,150
– – 0.22% 20
2022
Q4 		$205K Buy
+4,150
New +$170K 0.18% 28
2022
Q2 		– Sell
-4,150
Closed -$290K – 24
2022
Q1 		$290K Buy
4,150
+150
+4% +$11K 0.23% 20
2021
Q4 		$311K Buy
+4,000
New +$353K 0.24% 14

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Leverty Financial Group's EXAS Position: Q4 2025 in Review

Leverty Financial Group sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 4,000 shares — an estimated $219K sold.

Leverty Financial Group first reported a position in EXAS in Q4 2021 and held it in 12 quarters. The position peaked at $376K in Q2 2023. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Leverty Financial Group reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Leverty Financial Group sold 4,000 Exact Sciences shares in Q4 2025, an estimated $219K.
  • Leverty Financial Group first reported a position in Exact Sciences in Q4 2021 and held it in 12 quarters.
  • Leverty Financial Group's Exact Sciences position peaked at $376K in Q2 2023.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Leverty Financial Group's 13F filing for Q4 2025, filed 9 Jan 2026.